Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -4 of 4
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
A Phase II Single Arm Open-Label Clinical Trial of Chemotherapy of BCCs With Tazarotene 0.1% in Subjects With Basal Cell Nevus Syndrome
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Prevention, Treatment
Active
18 to 75
Other
2007-018
NCT00500643
2.
Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II, Phase I
Treatment
Active
18 and over
Other
McG 0722
NCT00779896
Last Modified:
10/30/2008
 
First Published:
6/15/2007
3.
Phase II Study of Topical Tazarotene in Patients With Basal Cell Nevus Syndrome and Basal Cell Carcinoma on the Face
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 to 75
NCI
CHORI-2007-016
UCSF-05862, R01-CA-109584, NCT00489086, 05862
First Published:
10/30/2008
4.
Phase II Randomized Study of Tazarotene Applied to Patients with Basal Cell Carcinoma and Basal Cell Nevus Syndrome on the Chest and Back
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Treatment
Active
18 - 75
NCI
CHORI-2007-022
05862, CHORI-H473-26042, NCT00783965
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute